Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Didn't hold above $5. Droped back to 4.93 and tried to come back.
Finished at 4.98 so maybe with some good news it goes higher ???
I think it will drop down below 4.80 one more time before pushing up????????????
Has to break and hold above $5
Maybe today????
Something is going on? Good news on finance and stock goes down???? What am I missing. Statement by Co said QTR doing better. I can see stabilizing but not dropping?? cheers
I have found I use amazon more for things I already know and have not been changed. Local store no longer carries the item. Or I dont need right away but will need in future. Also save to get multiple items so no shipping charge.
Usually find I end up paying a little more, i.e. full list vs sale but convenience wins.
They will survive if adapt to new climate??
JCP already started this process so I feel they will survive but untill new game has been learned for sure ??? will be rough going.
I do think next quarterly report will help this stock
Looking for $7.00
Cheers
Nice climb today again. Sure wish it would hold $5 something.
Thinly traded nano cap GTx (NASDAQ:GTXI) jumps 14% premarket on average volume in response to its announcement of positive interim results from a Phase 2 proof-of-concept study assessing enobosarm (GTx-024) for the treatment of postmenopausal women with stress urinary incontinence (SUI). The data will be presented at the International Continence Society's Annual Meeting in Florence September 12 - 15.
Yes but if bought low chart is getting Pretty
Personally low is in and stock is recovering. Probably see a pop next quarter when results and earnings posted.
Correction shoulnt it be $4.83 Cheers
Fri marching up nice
Can it bust resistance at 4>93 ??
Go JCP
Marching back to $5
Be nice everyone
CNBC
Analyst on CNBC talking up JCP
Main point is doing better than other stores due to dept down and cash flow improving
I think they will all survive in some shape
Most problems brought on by managment
As soon as the economy gets going and they pay of there loans things get better
There will be ups and downs along the way
If memory service me every one said Pennies will go into bankruptsy and disapear a while back?
There was a conversation on the financial chanel this am that 90% of all money spent still spent in stores.
GO JCP
I did not think of the funds selling if stock hit $5.
I think its way over sold
Most problems behind company and appear to be moving fwd slowley
Cheers
Phase 3 news
09:29 AM EDT, 03/30/2017 (MT Newswires) -- Acasti Pharma(ACST) gained more than 11% in premarket trade Thursday after it said it would proceed with its Phase 3 development program for CaPre, following its recent end-of-Phase 2 meeting with the U.S. Food and Drug Administration.
CaPre is an omega-3 drug derived of krill oil being developed for the treatment of patients with hypertriglyceridemia, a metabolic condition that contributes to the risk of cardiovascular disease and pancreatitis.
Sell Spread
Keep an eye on spread Bid/Ask have seen .10 to .40 cents this am in 30 min
Interesting but couple questions
Any one know the expected date od NDA filing? Was a meeting to discuss with FDA back on Nov 17? but never say anynews on when filing will happen??
Cant find current burn rate to see how much money they have left to operate? Seems some money should be coming in from all these countries??????????
Thanks in advance
Thanks
I haven't received vote info yet?
Worried vote will dilute value before Results????
Please advise date of vote thanks
Thanks The D works
Presentation
Dont see a pop after todays presentation
Anyone know how to get transcript??
Nice article, thanks for the find
Second R/S this year. Dont forget the 1 for 15 Jan 7, 16
Thanks for posting
Saw the posting this am and that it new and was preparing to sell shares due to more dilution. Cheers
Checking Etrade they show only 35.3% institutional owner ship but dont see a date?
Etrade and Fid match on 7.7 M shares outstanding.
Interesting? Think it hinges on when reported????
Did not expect to see that much of a difference??
Using Fid top 10 holders list Sarissa as of 9/30/16 dont hold shares. Looks like they HAD 30.8 mil but no more?????
DD Institutional ownership at 96.2% and Anson at 65.85%
Vanguard Group 18.05%
Health care value 5.69%
Calpers 3.34%
4 others have small amounts
We little folks need big crumbs to fall ????????????
Cheers
Very slow day.
I was hoping for a 2-3 cent pop?
Maybe tomorrow
Sheep hearder over slept this am
23 minutes into the day and 5000 share purchase.
Has slowed down
So much for morning pop?
Last R/S was 12/23/15, also aproved issuence of $23.5 million notes and warrents.
Form 4 Director bought
Can some one explain why this stock is moving at all???
Pending RS and or go out of business???
GTx Meets Primary Efficacy Endpoint In Phase 2 Study On Breast Cancer Drug
07:46 AM EST, 12/08/2016 (MT Newswires) -- GTx (GTXI), a biopharmaceutical company, said it met its primary efficacy endpoint in an ongoing phase 2 trial of enobosarm in breast cancer patients.
The company said the study evaluated women with advanced, estrogen receptor positive androgen receptor positive breast cancer. In the 9 mg cohort a total of 9 of 22 patients achieved a clinical benefit response at 24 weeks, with two patients seeing a partial response and seven with stable disease at 24 weeks.
Enobosarm 9 mg appears to be safe and generally well tolerated, the company said. The independent safety monitoring committee met on Dec. 1 and recommended the trial continue as planned. The company plans to report top-line clinical results following completion of the trial, which is anticipated in mid-2017.
GTx to Implement a 1-for-10 Reverse Stock Split
08:52 AM EST, 12/05/2016 (MT Newswires) -- GTx (GTXI), a biopharmaceutical company, said Monday that it will implement a 1-for-10 reverse stock split of common stock, effective on Dec. 5, to regain compliance with the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Shares will begin trading on a split-adjusted basis on Dec. 6 and the number of shares outstanding will be reduced to approximately 15.9 million.
What am I missing.
This Co did a RS a year ago and has gone straight down.
They announce another RS coupled with more shares and CO price jumps
WHY
This should really be at $.01?
As shareholders we should not vote for the RS again
05:01 PM EDT, 10/20/2016 (MT Newswires) -- Apricus Biosciences(APRI) will undertake a reverse stock split at a ratio of 1-for-10, taking effect on Friday after the close.
The adjusted stock will start trading Oct. 24. The reverse split will bring the company's issued and outstanding stock to about 7.7 million shares.
05:01 PM EDT, 10/20/2016 (MT Newswires) -- Apricus Biosciences(APRI) will undertake a reverse stock split at a ratio of 1-for-10, taking effect on Friday after the close.
The adjusted stock will start trading Oct. 24. The reverse split will bring the company's issued and outstanding stock to about 7.7 million shares.
05:01 PM EDT, 10/20/2016 (MT Newswires) -- Apricus Biosciences(APRI) will undertake a reverse stock split at a ratio of 1-for-10, taking effect on Friday after the close.
The adjusted stock will start trading Oct. 24. The reverse split will bring the company's issued and outstanding stock to about 7.7 million shares.